Hydrochlorothiazide and Photosensitivity: Side Effects & Sun Protection

Hydrochlorothiazide (HCTZ) is one of the most widely prescribed medications in the world — a thiazide diuretic used to treat hypertension and edema. It is also one of the most significant causes of drug-induced photosensitivity, with growing evidence linking it to squamous cell carcinoma of the lip with long-term use.

HCTZ and Photosensitivity: The Evidence

Hydrochlorothiazide causes phototoxic cutaneous reactions — dose-dependent, UV-A-mediated skin damage that does not require prior sensitization. Key clinical facts:

• Published case reports and pharmacovigilance data have identified HCTZ as a significant photosensitizer since the 1960s
• A major 2018 study from Denmark found that patients who had taken HCTZ for more than 10 years had a 7-fold increased risk of lip squamous cell carcinoma (a UV-sensitive site), raising serious concerns about cumulative photodamage
• The European Medicines Agency (EMA) updated HCTZ prescribing information in 2019 to include a warning about increased skin cancer risk with high cumulative doses

Mechanism

HCTZ contains a sulfonamide group that absorbs UV-A radiation. Upon UV absorption:

1. The excited HCTZ molecule generates reactive oxygen species (ROS) and free radicals
2. These damage DNA and cell membranes in sun-exposed skin
3. Cumulative DNA damage can drive malignant transformation in sun-exposed areas

Clinical Presentation

Acute HCTZ photosensitivity presents as:

• Exaggerated sunburn in UV-exposed areas
• Erythema, edema, occasionally blistering
• Sharp demarcation at clothing lines
• Onset within hours of sun exposure

Chronic reactions (long-term use):

• Actinic changes: solar keratoses, diffuse hyperpigmentation
• Increased squamous cell carcinoma risk (especially lip, scalp, face)
• Non-melanoma skin cancer risk elevated 1.5–4× with prolonged use

Prevention

Sun protection is critical for all HCTZ users, especially long-term:

• Broad-spectrum SPF 50+ sunscreen daily on all exposed areas
• UV-protective lip balm SPF 30+ — especially important given the lip SCC data
• Wide-brim hat, sun-protective clothing
• Avoid peak UV hours (10am–4pm)
• Annual skin check with a dermatologist, especially for patients with >3 years of use

Alternative antihypertensives with lower photosensitivity risk:

• ACE inhibitors (lisinopril, ramipril)
• ARBs (losartan, valsartan)
• Calcium channel blockers (amlodipine)
• Indapamide (different thiazide-like diuretic with lower photosensitivity evidence)

For patients requiring HCTZ for volume management (heart failure, resistant hypertension), the benefits may outweigh the risks with appropriate sun protection.

Sources

1. Pottegård A, et al. “Hydrochlorothiazide use and risk of nonmelanoma skin cancer.” J Am Acad Dermatol. 2017;76(6):1067-1072.
2. European Medicines Agency. “Hydrochlorothiazide: Updated EU product information.” 2019.
3. Moore DE. “Drug-induced cutaneous photosensitivity.” Drug Saf. 2002;25(5):345-372.